For decades, the pharmaceutical industry has claimed that research costs are the reason American drugs are so expensive compared to the rest of the world. However, recently revealed facts show that many of these firms spend more on advertising than on research, some more than twice as much. For several years now, Americans have been bombarded with TV ads for prescription medications. In 2013, pharmaceutical manufacturers spent nearly $4 billion on direct-to-consumer television, radio, online, magazine and newspaper advertising. Drug makers now market their products directly to consumers, rather than the traditional method of allowing doctors to make treatment recommendations. Pharmaceutical companies often air ads for products that treat sexual dysfunction, incontinence, pain, hormone imbalance or depression -followed by lengthy warnings of possible horrific side-effects from using their products. Some critics claim these types of ads are not appropriate to be viewed by children. They also say drug ads are not produced by people who are experts in healthcare, but who are somewhat competent in sales and marketing. These ads should be considered for what they are, a promotion, not a source of factual consumer information. Advocates claim most consumers are not adequately informed to assess the accuracy or truth of a drug ad, or whether it is appropriate for their condition, or if they even have a condition that requires such medication.
H.R.923 – Say No to Drug Ads Act
I oppose reforming current pharmaceutical advertising policy and wish to defeat H.R.923
I support amending the Internal Revenue Code to deny a tax deduction for the cost of direct-to-consumer advertisement of a prescription drug, and wish to pass H.R.923